http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107412152-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4174
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
filingDate 2016-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107412152-B
titleOfInvention Dexmedetomidine hydrochloride injection composition
abstract The invention belongs to the technical field of medicines, and particularly relates to a dexmedetomidine hydrochloride injection composition. The dexmedetomidine hydrochloride injection composition comprises dexmedetomidine hydrochloride, reduced glutathione, sodium chloride and water for injection. The mass ratio of dexmedetomidine hydrochloride to reduced glutathione in the injection composition is 0.6: 1-4: 1. Compared with the prior art, the dexmedetomidine hydrochloride injection composition has the advantages of good light stability, difficult generation of visible foreign matters, convenient long-term storage, safe clinical use, good curative effect and small generated side effect. In addition, the dexmedetomidine hydrochloride injection composition has the advantages of simple preparation process, lower cost and convenience for industrial production.
priorityDate 2016-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453416342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23462
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5240
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581463
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311068
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507591
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5206
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124886
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441351
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452063286
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451652865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492786
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23963
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552989

Total number of triples: 52.